Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336503 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
A Phase 2 study of Hyperhidrosis, sponsored by Botanix Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 189
- Enrollment target
- 12
- Study locations
NCT02336503 is a Phase 2 study of Hyperhidrosis that has completed, run by Botanix Pharmaceuticals. The registered enrollment target is 189 participants, above the 76-participant average among 8 other Hyperhidrosis trials with a reported enrollment target (149% higher). The trial reports 12 study locations across 8 states.
The verdict
NCT02336503, a Phase 2 study of Hyperhidrosis, has completed, sponsored by Botanix Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 189 participants
- Enrollment target
- 12
- Study locations
Study Summary
To assess the safety and efficacy of 3 doses of BBI-4000 and vehicle (4 treatment arms), when applied once a day for 4 weeks, for the treatment of axillary hyperhidrosis.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG BBI-4000 Gel, 5%
- DRUG BBI-4000 Gel, 10%
- DRUG BBI-4000 Gel, 15%
Study Locations (12)
Florida
- Center for Clinical and Cosmetic Research - Aventura
- International Dermatology Research, Inc. - Miami
- International Clinical Research - Sanford
California
- Center for Dermatology Clinical Research, Inc. - Fremont
- Therapeutics Clinical Research - San Diego
Indiana
- Shideler Clinical Research Center - Carmel
- The Indiana Clinical Trials Center - Plainfield
Minnesota
- Minnesota Clinical Study Center - Fridley
Missouri
- Saint Louis University Dermatology - St Louis
New Mexico
- Academic Dermatology Associates - Albuquerque
Texas
- The Center for Skin Research - Houston
Virginia
- Virginia Clinical Research, Inc. - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2015-03-10 |
| Est. Completion | 2015-11-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02336503
The ClinicalTrials.gov registry entry for NCT02336503 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 8 other Hyperhidrosis trials with a reported enrollment target (149% higher). The listed sponsor is Botanix Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperhidrosis appearing as the primary indexed condition, and to 4 interventions - of which Vehicle is the first listed.
NCT02336503 reports 12 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT02336503 about?
NCT02336503 is a clinical study titled "A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis". To assess the safety and efficacy of 3 doses of BBI-4000 and vehicle (4 treatment arms), when applied once a day for 4 weeks, for the treatment of axillary hyperhidrosis.
What is the current status of trial NCT02336503?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 189 participants. The study started on 2015-03-10. Estimated completion is 2015-11-05.
What conditions does trial NCT02336503 study?
This clinical trial studies the following conditions: Hyperhidrosis.
What interventions are being tested in trial NCT02336503?
The interventions under investigation include: Vehicle (DRUG), BBI-4000 Gel, 5% (DRUG), BBI-4000 Gel, 10% (DRUG), BBI-4000 Gel, 15% (DRUG).
Who is sponsoring clinical trial NCT02336503?
This trial is sponsored by Botanix Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02336503 being conducted?
This trial has 12 study locations across California, Florida, Indiana, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperhidrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
COMPLETED · Phase 2
-
Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis
COMPLETED · Phase 2
-
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects
COMPLETED · Phase 2
-
An Open Label Study for Palmar Hyperhydrosis
COMPLETED · Phase 2
-
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
COMPLETED · Phase 2
-
Botulinum Toxin Therapy in Hidradenitis Suppurativa
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.